Search results
Results from the WOW.Com Content Network
Johnson & Johnson (NYSE: JNJ) has reached a A$300 million settlement in two Australian class action suits filed by Shine Lawyers for selling defective pelvic mesh implants to Australian women. The ...
At the same time, another law firm has joined Kline & Specter in criticizing the set-aside request, saying some of the fee requests have not been fair and that money for the common benefit fees ...
Michelle Roberts - Digital health editor, BBC News February 6, 2025 at 7:06 PM More than 100,000 women are believed to have had mesh implants fitted between 2007 and 2015 [BBC]
Transvaginal mesh, also known as vaginal mesh implant, is a net-like surgical tool that is used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) among female patients. The surgical mesh is placed transvaginally to reconstruct weakened pelvic muscle walls and to support the urethra or bladder.
However, the use of a transvaginal mesh in treating vaginal prolapses is associated with side effects including pain, infection, and organ perforation. According to the FDA, serious complications are "not rare." A number of class action lawsuits have been filed and settled against several manufacturers of TVM devices.
The most distal prolapse is between 1 cm above and 1 cm below the hymen (at least one point is −1, 0, or +1). 3: The most distal prolapse is more than 1 cm below the hymen but no further than 2 cm less than TVL. 4: Represents complete procidentia or vault eversion; the most distal prolapse protrudes to at least (TVL−2) cm.
In November 2022, Google agreed to pay a nearly $392 million settlement related to location tracking practices, the largest consumer privacy settlement ever reached by U.S. state attorneys general ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...